4
Changes in Ownership
Vivos Therapeutics, Inc. Filed Acc 0001493152-23-021525
Chief Executive Officer bought 10,000 shares at $0.49 ($4,900)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Huntsman Ronald Kirk Chief Executive Officer | 2023-06-14 | Purchase | +10,000 | $0.49 | $4,900 | 57,500 | D |
| Open-market purchases · 10,000 sh · avg $0.49 · $4,900 | |||||||
Loading xslF345X04/ownership.xml…